PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 37 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

17 June 2025

  1. (diff | hist) 05:03 Semaglutide 8,560 ±0 IcodecIndra (talk | contribs) correct the molar mass — source gives the free-base figure, we had the salt [rollback]
  2. (diff | hist) m 04:42 Qingdao Sigma Chemical 12,048 +478 SortKeySascha (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]

16 June 2025

  1. (diff | hist) m b 22:54 Insulin syringe unit conversion 5,079 +635 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  2. (diff | hist) 22:05 Peptide stability table 5,122 +231 NPOV_Nadia (talk | contribs) add the medical-disclaimer cross-link to the tool pages [rollback]
  3. (diff | hist) 16:20 STEP trial programme 5,114 +723 PioneerPerdita (talk | contribs) consistent en dashes in ranges [rollback]
  4. (diff | hist) m b 13:32 Guangzhou JEEP Biotechnology 12,229 +53 ArchiveBot (talk | contribs) bot: add supplier category [rollback]
  5. (diff | hist) 10:20 Customs seizure 3,644 ±0 ImportRecordIna (talk | contribs) add the year the guidance was issued [rollback]
  6. (diff | hist) 09:55 Zhuhai Kerui Biotechnology 4,188 +1,443 Hedgerow_Hal (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]
  7. (diff | hist) 08:21 Crude peptide 3,938 ±0 SPPS_Sorrel (talk | contribs) add the light-exposure point for photosensitive material [rollback]
  8. (diff | hist) 04:45 Sarcopenia 3,762 ±0 eGFR_Esme (talk | contribs) attribute the population interval to the cohort it was derived from [rollback]

15 June 2025

  1. (diff | hist) m 21:06 Flourishglobal Peptide Biotech 6,878 +377 VerifyFirstVida (talk | contribs) correct the regional-warehouse list — six sites, not five [rollback]
  2. (diff | hist) 19:26 Temperature excursion 10,117 +652 Chromatokid (talk | contribs) add the cross-link to the temperature-excursion article [rollback]
  3. (diff | hist) 18:09 Karl Fischer titration 7,949 ±0 SecondarySrc_Seb (talk | contribs) give the injection volume, without which the loading cannot be judged [rollback]
  4. (diff | hist) 18:04 GL Biochem (Shanghai) 14,304 ±0 UnderfillUna (talk | contribs) rm the price; supplier articles carry no price per PP:VN [rollback]
  5. (diff | hist) 17:05 TRIUMPH trial programme 4,035 ±0 FlowTrialFraser (talk | contribs) expand §What phase 3 is designed to address [rollback]
  6. (diff | hist) 14:50 GLP-1 receptor agonist 9,758 ±0 IcodecIndra (talk | contribs) serial comma per PP:MOS [rollback]
  7. (diff | hist) m 14:31 Glucagon-like peptide-1 11,430 +201 AmylinAmos (talk | contribs) correct the second-messenger pathway named in the lead [rollback]
  8. (diff | hist) 14:00 CagriSema 4,185 +18 TrialsTabitha (talk | contribs) add see also to the amylin analogue [rollback]
  9. (diff | hist) m 10:50 SELECT trial 4,851 ±0 DataTableDunja (talk | contribs) add the trial acronym expansion at first use [rollback]
  10. (diff | hist) m 08:25 Methionine oxidation 3,850 ±0 MassSpecMarv (talk | contribs) expand §Detection and control [rollback]
  11. (diff | hist) m b 04:13 Fasting insulin 3,910 ±0 CategoryBot (talk | contribs) bot: update parent category chain [rollback]

14 June 2025

  1. (diff | hist) m 21:07 Dipeptidyl peptidase-4 6,468 +446 EmptyingElke (talk | contribs) add the counter-regulatory glucagon point, sourced [rollback]
  2. (diff | hist) 19:50 Hypoglycaemia 4,417 +642 SVG_Solomon (talk | contribs) expand §Why glucose dependence matters [rollback]
  3. (diff | hist) m b 10:35 Receptor bias 4,000 +464 CiteBot (talk | contribs) bot: sort category members [rollback]
  4. (diff | hist) m 10:07 Hunan Aslsen Technology 10,642 +590 VerifyFirstVida (talk | contribs) expand §External links [rollback]
  5. (diff | hist) 08:29 Prior authorisation 3,517 ±0 RfC_Rasmus (talk | contribs) add the cross-link to the insurance article [rollback]
  6. (diff | hist) 08:07 ChinaPeptides 9,505 +199 LedgerLysander (talk | contribs) expand §Reception [rollback]
  7. (diff | hist) 05:42 Drug master file 4,092 +750 EndotoxinEd (talk | contribs) add the jurisdiction to the legal statement [rollback]
  8. (diff | hist) m 03:34 Retention time 3,764 +428 OffLabelOdile (talk | contribs) sentence case in headings per PP:MOS [rollback]
  9. (diff | hist) 00:17 Grey market 3,461 ±0 Chromatokid (talk | contribs) correct the transit-time figure — the source gives a median, not a maximum [rollback]

13 June 2025

  1. (diff | hist) 12:15 Preparative HPLC purification 4,598 ±0 BetaCellBoyd (talk | contribs) expand §Scale-up [rollback]
  2. (diff | hist) 12:13 Trifluoroacetate counterion 3,918 +19 LotTraceLuka (talk | contribs) space between number and unit per PP:MOS [rollback]
  3. (diff | hist) 10:18 Talk:Shanghai Sigma-Audley New Material Technology 1,170 +85 COA_Colwyn (talk | contribs) /* Packaging consistency: observation or compliment? */ reply
  4. (diff | hist) 10:02 Talk:Zhuhai Kerui Biotechnology 1,033 +81 PuffRemoverPax (talk | contribs) /* Method disclosure: are we writing an endorsement? */ reply
  5. (diff | hist) 08:54 Reference standard 4,806 ±0 DiluentDiya (talk | contribs) ce per PP:MOS [rollback]
  6. (diff | hist) m 08:27 Qingdao Saber Technology Pharmaceutical 2,112 +360 TirzTaxonomist (talk | contribs) sentence case in headings per PP:MOS [rollback]
  7. (diff | hist) m 07:40 Peptide 6,609 ±0 CounterfeitCato (talk | contribs) move a stray full stop inside the reference [rollback]
  8. (diff | hist) m 04:49 Hubei Jianxiang Bioscience 6,103 +630 TallySheetTad (talk | contribs) rm the adjective — an organisation article describes, it does not praise [rollback]
  9. (diff | hist) m 00:14 Cost per milligram 3,292 ±0 SecretagogueSol (talk | contribs) add the compounded-alternative point with its regulatory caveat [rollback]

12 June 2025

  1. (diff | hist) m 20:03 Baseline laboratory panel 4,222 ±0 DataTableDunja (talk | contribs) expand §Common components [rollback]
  2. (diff | hist) 12:39 Reverse-phase HPLC 5,116 ±0 SigFigSindri (talk | contribs) add the equilibration time to the gradient description [rollback]
  3. (diff | hist) 12:04 Gastric emptying 5,258 +606 LCellLeif (talk | contribs) add the species in which the knockout work was done [rollback]
  4. (diff | hist) m 11:07 Batch number 4,286 +555 BlindSampleBrid (talk | contribs) add the second-opinion point: two services, one lot, is a stronger record [rollback]
  5. (diff | hist) 08:55 Talk:Shanghai Sigma-Audley New Material Technology 959 +204 PrimarySrcPatia (talk | contribs) /* Packaging consistency: observation or compliment? */ reply
  6. (diff | hist) 08:49 Proglucagon 6,144 +401 ArcuateArt (talk | contribs) add short description [rollback]
  7. (diff | hist) 08:41 Talk:Temperature excursion 822 +186 ColdChainCleo (talk | contribs) /* Worked MKT example: check of the arithmetic */ reply
  8. (diff | hist) 08:19 Talk:Certificate of analysis 1,096 +79 HyphenHarriet (talk | contribs) /* Should the requested-items list be numbered? */ reply
  9. (diff | hist) 07:41 Talk:Glucagon-like peptide-1 1,370 +111 BaselineBex (talk | contribs) /* Should the fasting concentration range be in the infobox? */ reply
  10. (diff | hist) 06:30 Fmoc chemistry 4,618 +188 GHK_Gwendolen (talk | contribs) rm the vendor-specific packaging detail; not general enough for the article [rollback]
  11. (diff | hist) m 05:54 Liraglutide 5,268 ±0 DrTitration (talk | contribs) expand §Practical differences from weekly agents [rollback]
  12. (diff | hist) 05:39 Glucose-dependent insulinotropic polypeptide 6,898 ±0 EmptyingElke (talk | contribs) add a figure for the secretion time course and caption it [rollback]

11 June 2025

  1. (diff | hist) 23:56 Trial data comparison 5,448 +523 EscalationEira (talk | contribs) label the filter control so its state is announced [rollback]
  2. (diff | hist) 22:26 Resin cleavage 4,029 +725 SPPS_Sorrel (talk | contribs) expand §Cocktails and scavengers [rollback]
  3. (diff | hist) m b 22:14 Beyond-use date 15,368 +1,696 StubSorterBot (talk | contribs) bot: add stub category [rollback]
  4. (diff | hist) 15:26 Talk:Certificate of analysis 885 +237 Retention_Time_Rae (talk | contribs) /* Should the requested-items list be numbered? */ reply
  5. (diff | hist) 13:02 Talk:Shanghai Sigma-Audley New Material Technology 748 +222 StyleSheetSybil (talk | contribs) /* Packaging consistency: observation or compliment? */ reply
  6. (diff | hist) 12:07 Talk:Temperature excursion 611 +233 StabilityStig (talk | contribs) /* Worked MKT example: check of the arithmetic */ reply
  7. (diff | hist) 10:08 Talk:Certificate of analysis 674 +130 HyphenHarriet (talk | contribs) /* Should the requested-items list be numbered? */ new section
  8. (diff | hist) 10:02 Talk:Glucagon-like peptide-1 1,159 +247 AnalyticalAnnie (talk | contribs) /* Should the fasting concentration range be in the infobox? */ reply
  9. (diff | hist) 09:40 Talk:Shanghai Sigma-Audley New Material Technology 537 +366 COA_Colwyn (talk | contribs) /* Packaging consistency: observation or compliment? */ new section
  10. (diff | hist) 09:35 Talk:Zhuhai Kerui Biotechnology 822 +230 Hedgerow_Hal (talk | contribs) /* Method disclosure: are we writing an endorsement? */ reply
  11. (diff | hist) 09:33 Talk:Temperature excursion 400 +402 UnitAuditUwe (talk | contribs) /* Worked MKT example: check of the arithmetic */ new section
  12. (diff | hist) 09:05 Survodutide 4,510 ±0 NotabilityNoa (talk | contribs) add CAS number, sourced [rollback]
  13. (diff | hist) N 09:00 Qingdao Saber Technology Pharmaceutical 1,752 +1,752 GroupBuyGalen (talk | contribs) create organisation article per PP:VN
  14. (diff | hist) 08:24 Talk:Glucagon-like peptide-1 948 +161 BaselineBex (talk | contribs) /* Should the fasting concentration range be in the infobox? */ new section
  15. (diff | hist) m b 03:47 SURMOUNT trial programme 4,572 +983 StubSorterBot (talk | contribs) bot: expand PMID to full citation [rollback]

10 June 2025

  1. (diff | hist) 23:59 LEADER trial 4,171 +605 ManualOfStyleMo (talk | contribs) expand §Place in the evidence [rollback]
  2. (diff | hist) 22:00 Zhuhai Kerui Biotechnology 2,745 +234 ColdChainCleo (talk | contribs) add the reception tally with its period and count stated [rollback]
  3. (diff | hist) 21:07 Adverse effects of GLP-1 receptor agonists 5,314 ±0 AnaesthesiaAoife (talk | contribs) clarify that the rodent finding has not been observed in humans [rollback]
  4. (diff | hist) 14:22 Talk:Zhuhai Kerui Biotechnology 611 +445 AnalyticalAnnie (talk | contribs) /* Method disclosure: are we writing an endorsement? */ reply
  5. (diff | hist) 11:48 Talk:Zhuhai Kerui Biotechnology 400 +174 PuffRemoverPax (talk | contribs) /* Method disclosure: are we writing an endorsement? */ new section
  6. (diff | hist) 11:13 Test report forgery 4,203 ±0 ProglucagonPia (talk | contribs) split §What a report shows from §What it does not [rollback]
  7. (diff | hist) 07:25 WuXi TIDES 11,915 +312 ReaderRosalie (talk | contribs) add category for suppliers in China [rollback]
  8. (diff | hist) 04:34 Chinese Peptide Company 13,077 +1,288 ForgeryFinder (talk | contribs) unpipe a link that did not need piping [rollback]
  9. (diff | hist) 03:14 Contraindications of incretin therapy 4,296 ±0 ListMakerLumi (talk | contribs) add the placebo rate next to the treatment rate [rollback]

9 June 2025

  1. (diff | hist) 21:02 Wuhan Wansheng Biotechnology 12,221 +902 BlankVialBo (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  2. (diff | hist) m 17:38 Chain of custody 4,708 +606 PrepHPLC_Pia (talk | contribs) add the laboratory accreditation status, or say plainly that it is not stated [rollback]
  3. (diff | hist) m 16:56 Missed dose 5,031 +42 EscalationEira (talk | contribs) rm the titration schedule — that belongs on the compound article [rollback]
  4. (diff | hist) m 12:56 Xi'an Mokemei Biotechnology 6,319 +538 Ref_Desk_Ron (talk | contribs) correct the other-designations row — those are trading variants, not subsidiaries [rollback]
  5. (diff | hist) 12:26 Peptide harm reduction 3,975 ±0 ReaderRosalie (talk | contribs) add the compounded-alternative point with its regulatory caveat [rollback]
  6. (diff | hist) 05:48 Global access disparity 3,508 +194 PriorAuthPaz (talk | contribs) clarify that a discontinued shortage listing changed the compounding position [rollback]

8 June 2025

  1. (diff | hist) 13:45 Underfilling 3,863 ±0 SarcopeniaSefa (talk | contribs) correct the description of how lot identifiers are assigned [rollback]
  2. (diff | hist) 11:54 Liquid chromatography-mass spectrometry 3,742 +18 LOD_Lorcan (talk | contribs) add the note on co-elution and what it hides [rollback]
  3. (diff | hist) 02:59 Glucagon 6,619 +577 LedeLeander (talk | contribs) correct the dose ladder — the maintenance dose is not the maximum dose [rollback]
  4. (diff | hist) 02:41 Peptide content 6,925 +27 ColumnOvenCoy (talk | contribs) expand §Why it is so often absent [rollback]

7 June 2025

  1. (diff | hist) 23:36 Research use only 7,423 +712 API_Aurora (talk | contribs) add the patent-expiry statement, attributed and dated [rollback]
  2. (diff | hist) 19:22 International nonproprietary name 4,000 +817 DulaglutideDug (talk | contribs) state the substitution in one-letter code as well, per PP:MOS [rollback]
  3. (diff | hist) 18:55 GLP-1 receptor 7,031 +361 SatietySunniva (talk | contribs) ce per PP:MOS [rollback]
  4. (diff | hist) 17:42 Body composition assessment 4,416 ±0 ResolutionRoo (talk | contribs) fix indentation in the source [rollback]
  5. (diff | hist) 14:11 Sterility testing 3,663 +27 ResolutionRoo (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]
  6. (diff | hist) 07:41 Reconstitution calculator 7,305 +325 DeletionDeb (talk | contribs) the calculator rounded before dividing; corrected [rollback]
  7. (diff | hist) 03:11 Peptide aggregation 4,377 ±0 Areapercent_Ayo (talk | contribs) correct the flow rate — the source gives it in mL/min [rollback]

6 June 2025

  1. (diff | hist) 22:34 Incretin effect 6,953 +1,020 HalfLifeHavel (talk | contribs) fix a broken wikilink [rollback]
  2. (diff | hist) 21:08 Contract development and manufacturing organisation 4,216 ±0 AnalyticalAnnie (talk | contribs) add the cross-link to the temperature-excursion article [rollback]
  3. (diff | hist) 17:07 VendorInvestigate 4,918 +23 AAA_Analyst (talk | contribs) add the chain-of-custody point to §Limitations [rollback]
  4. (diff | hist) m 14:10 Peptide synthesis 4,967 +833 PrepHPLC_Pia (talk | contribs) add the light-exposure point for photosensitive material [rollback]
  5. (diff | hist) m 13:54 SURPASS trial programme 4,474 ±0 NauseaNoor (talk | contribs) the percentage quoted was placebo-adjusted; label it [rollback]
  6. (diff | hist) m 12:10 Weight regain after discontinuation 4,624 +576 NAION_Noel (talk | contribs) add the citation for the gallbladder finding [rollback]
  7. (diff | hist) m b 08:47 Subcutaneous injection 4,640 ±0 CategoryBot (talk | contribs) bot: sort category members [rollback]
  8. (diff | hist) 08:13 Triple agonist 3,987 +559 DeadSpaceDot (talk | contribs) give the isoelectric point with the method it was determined by [rollback]